Kim Donghee, Danpanichkul Pojsakorn, Wijarnpreecha Karn, Ahmed Aijaz
Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, United States.
Diabetes Res Clin Pract. 2025 Aug;226:112340. doi: 10.1016/j.diabres.2025.112340. Epub 2025 Jun 24.
To examine the current affordability of healthcare and prescription medicine for adults with diabetes.
Data from US National Health Interview Survey 2020-2023 were utilized in a cross-sectional analysis to investigate healthcare and prescription medication affordability among individuals with diabetes.
Among the 117,536 adults (weighted sample: 253 million), 9.6 % reported diabetes. Individuals with diabetes indicated lower healthcare affordability compared to their non-diabetic counterparts. Among individuals with diabetes, 11.4 % (95 % confidence interval [CI]: 10.7-12.1 %), estimated 2.7 million individuals, reported their inability to pay their medical bills.Factors such as nonelderly age (<65 years), female, low-income status, non-Hispanic Black and Hispanic individuals, higher comorbidity burden, and lack of insurance were independently associated with financial hardship.Individuals with diabetes consistently faced challenges in affording their prescription medications, with 14.3 % (95 % CI: 13.5-15.1 %) experiencing cost-related medication nonadherence, higher than the general US adult population at 9.6 % (95 % CI: 9.3-9.9 %). Younger age (<65 years), female gender, low-income status, South or West region residence, higher comorbidity burden, and lack of insurance were independently correlated with cost-related medication nonadherence.
Adults with diabetes face challenges in healthcare and prescription medication affordability compared to those without diabetes and the general population, particularly evident among nonelderly adults.
研究目前糖尿病成年人获得医疗保健和处方药的可负担性。
利用2020 - 2023年美国国家健康访谈调查的数据进行横断面分析，以调查糖尿病患者的医疗保健和处方药可负担性。
在117,536名成年人（加权样本：2.53亿）中，9.6%报告患有糖尿病。与非糖尿病患者相比，糖尿病患者表示医疗保健可负担性较低。在糖尿病患者中，11.4%（95%置信区间[CI]：10.7 - 12.1%），估计有270万人报告无力支付医疗账单。非老年年龄（<65岁）、女性、低收入状态、非西班牙裔黑人和西班牙裔个体、更高的合并症负担以及缺乏保险等因素与经济困难独立相关。糖尿病患者在负担处方药方面一直面临挑战，14.3%（95% CI：13.5 - 15.1%）的患者出现与费用相关的药物治疗不依从，高于美国普通成年人群的9.6%（95% CI：9.3 - 9.9%）。年龄较小（<65岁）、女性、低收入状态、居住在南部或西部地区、更高的合并症负担以及缺乏保险与与费用相关的药物治疗不依从独立相关。
与非糖尿病患者和普通人群相比，糖尿病成年人在获得医疗保健和处方药方面面临挑战，在非老年成年人中尤为明显。
